pharmacycanada-rxedtop

Admissions still low among Hispanic neighborhoods and for respiratory diseases — ScienceDaily

While declines in U.S. hospital admissions during the onset of COVID-19 has been well-documented, little is…

FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress

ENGLEWOOD, Colo., Sept. 21, 2020 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company”) announces the receipt…

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

ARDS program well-positioned for an expedited path to commercialization with RMAT and Fast Track designation Athersys,…